Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Ophthalmic Research|May 23, 2019
Semifluorinated Alkane Eye Drops in Chronic Ocular Graft-versus-Host Disease: A Prospective, Multicenter, Noninterventional StudyPhilipp Eberwein, Sonja Krösser, Philipp Steven
Klinische Monatsblatter Fur Augenheilkunde|May 16, 2017
[Influence of Aging on Severity and Anti-Inflammatory Treatment of Experimental Dry Eye Disease]Philipp Steven, Tobias Braun, Sonja Krösser, et al.
Ophthalmology|July 27, 2025
Corneal Staining Responder Analysis: A Clinically Meaningful Dry Eye OutcomeEsen K Akpek, John D Sheppard, Sonja Krösser
Biopharmaceutics & Drug Disposition|July 27, 2007
Investigation of the impact of sarizotan on the pharmacokinetics of levodopaSonja Krösser, Roland Neugebauer, Didier Chassard, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|May 13, 2023
Preclinical characterization of water-free cyclosporine eye drops - Factors impacting ocular penetration ex vivo and in vivoPriyanka Agarwal, Johannes Korward, Sonja Krösser, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|January 17, 2017
A semifluorinated alkane (F4H5) as novel carrier for cyclosporine A: a promising therapeutic and prophylactic option for topical treatment of dry eyeUta Gehlsen, Tobias Braun, Maria Notara, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|August 22, 2015
Semifluorinated Alkane Eye Drops for Treatment of Dry Eye Disease--A Prospective, Multicenter Noninterventional StudyPhilipp Steven, Dieter Scherer, Sonja Krösser, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|November 28, 2024
Pooled results from two pivotal randomized controlled clinical trials: ESSENCE-1 and ESSENCE-2 to assess efficacy and safety of a water-free ciclosporin 0.1% formulation for the treatment of dry eye diseaseThomas Kaercher, John D Sheppard, Adam Hamm, et al.
Clinical Pharmacology in Drug Development|April 29, 2016
Absolute Bioavailability and Effect of Food on the Disposition of Safinamide Immediate Release Tablets in Healthy Adult SubjectsAnnick Seithel-Keuth, Andreas Johne, Achim Freisleben, et al.
Journal of Cataract and Refractive Surgery|February 9, 2024
Efficacy of a new water-free topical cyclosporine 0.1% solution for optimizing the ocular surface in patients with dry eye and cataractEsen K Akpek, John D Sheppard, Adam Hamm, et al.
Pageof 4